Sotera Health CFO Says Growth Story Intact, Sees 2026 Organic Growth of 5%-6.5% at KeyBanc Forum

TL;DR

According to finance.yahoo.com, key Points - CFO Jon Lyons reiterated constant-currency organic growth guidance of 5% to 6.5% for 2026, with Sterigenics expected to deliver mid‑ to high‑single‑digit growth, Nordion low‑ to mid‑single digits, Nelson Labs low‑single digits, and pricing expected near the midpoint of the 3%–4% long‑term guide while volumes remain the biggest swing factor.